United Kingdom (UK) Biobanking Market Research Report, 2029

The biobanking sector in UK is thriving booming with several advancement of pharmaceutical development, healthcare delivery, and biomedical research. A strong network of biobanks connected to government offices, hospitals, research center's, and academic universities. Large collections of biological samples, such as blood, tissue, cells, and DNA, as well as related clinical and general information, are kept in these biobanks. UK have one of the largest population-based biobanks in the globe. Research projects in basic science, clinical trials, and translational medicine are all supported by UK biobanks. The UK biobanking ecosystem is increasing through innovation and regular trials also through collaboration. Sample processing, storage, and analysis workflows have been completely transformed through development in biobanking technologies. Digital platforms, robotics, and automated systems improve the scalability, durability, effectiveness and efficiency of biobank operations. Integrating omics technologies allows for thorough molecular profiling of biological samples for applications in precision medicine and customized healthcare facility, including proteomics, metabolomics, and genomes. According to the research report " United Kingdom Biobanking Market Research Report, 2029," published by Actual Market Research, the United Kingdom Biobanking market was valued at more than USD 6 Billion in 2023. The biobanking industry in the UK is growing need for high-quality biological samples and related data as our knowledge of illnesses and therapies develops. Biobank sectors are important because they give researchers access to well-characterized samples from a wide range of population. The collection, storage, and analysis of biological samples has become simpler and more affordable. The government and private agencies are funding in biobank ultimately result of these technical advancements, which have also increased their capacities.

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

The primary elements which are used in the UK such as Equipment consumables, and laboratory information systems (LIS) to define biobanking. Equipment is an essential part of the biobanking system as well, encompassing a wide range of instruments required for sample preservation, storage, and analysis. Examples of this include automated liquid handling systems, ultra-low temperature freezers, and specialized bio preservation equipment built to maintain sample integrity over extended periods of time. The dependability and efficiency of such equipment, which ensures the preservation of biological specimens under optimum conditions for later research projects, is significantly responsible for the effectiveness of biobanking activities. Consumables products are necessary complement to the equipment portion that help biobanking facilities collection, process, and store samples efficiently. Reagents, sample collection tubes, cryogenic vials, labelling supplies, and a variety of other items are among them. The services types like Cold chain logistics, lab processing, validation/qualification, biobanking and repositories, and other are among that the UK uses. These services cover the collection, handling, and storage of biological samples along with associated data. Various biological resources, including blood, tissue, DNA, and cells, are stored in biobanks. Services include things like quality control, accessioning, long-term storage, and providing samples to researchers for use in scientific studies. Services for certification and validation ensure that biological samples and associated data stored in biobanks are accurate, consistent, and of high quality. Essential for maintaining data repeatability, adhering to rules, and enhancing the biobank resources' scientific utility. A wide range of activities related to sample preparation, analysis, and characterization are included in the services for lab processing. Physical biobanks are the store biological samples and associated data in physical form, such as blood, tissue, DNA, and cells. These biobanks maintain collections of samples sourced from individuals, patients, and populations for use in medical research, diagnostics, and therapeutic development. It is centralized facilities or distributed across multiple locations, such as hospitals, research institutions, and academic centers. Virtual biobanks, also known as registry-based biobanks or data-driven biobanks, store information about biological samples and associated data in digital or electronic formats, rather than storing physical specimens. These biobanks typically consist of databases or registries containing anonymized or de-identified health information, genomic data, and other clinical or phenotypic data collected from individuals or patient cohorts. Virtual biobanks enable researchers to access and analyze large datasets for epidemiological studies, genetic research, and clinical trials without directly accessing physical samples.

Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Ask an Expert

Kripa Shah

Senior Analyst

Drug discovery and clinical research, treatments, clinical diagnostics, and other factors are the basis for segmentation in the United Kingdom. Biobanks are essential for drug discovery and clinical research because they give researchers access to a wide range of biological sample collections and related data. These samples are utilized to evaluate medication targets, find illness biomarkers, and create novel therapeutic approaches. Biobanks aid in translational research by providing the means to identify and validate new biomarkers, characterize disease mechanisms, and assess the safety and efficacy of drugs in preclinical and clinical trials. By giving academics and pharmaceutical companies access to well-characterized biological samples for use in preclinical and clinical trials, biobanks aid in the development of therapeutic interventions. These specimens are employed to detect possible. Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029 Aspects covered in this report • Biobanking market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Product Type • Equipment • Consumables • Laboratory Information Systems By Service Type • Biobanking and Repository • Validation/Qualification • Lab Processing • Cold Chain Logistic • Others By Biospecimen Type • Human Tissues • Stem Cells • Organs • Others By Biobank • Physical Biobanks • Virtual Biobanks By Application • Drug Discovery and Clinical Research • Therapeutics • Clinical Diagnostics • Others By Type of Biobank • Population-based Biobanks • Disease-oriented Biobanks By Ownership • National/regional agency • Non-Profit Organization • Universities • Private Organization By Storage • Manual Storage • Automated Storage The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Biobanking industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.